Sean D. Buckley
Directeur Technique/Scientifique/R&D chez IMMUNOCORE HOLDINGS PLC
Postes actifs de Sean D. Buckley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 01/09/2021 | - |
Historique de carrière de Sean D. Buckley
Anciens postes connus de Sean D. Buckley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARMELL CORPORATION | Directeur Financier/CFO | 01/01/2022 | 01/09/2022 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01/12/2019 | 01/01/2021 |
| FIBROCELL SCIENCE, INC. | Directeur Administratif | 01/10/2011 | - |
| Directeur Technique/Scientifique/R&D | 01/08/2013 | 01/01/2017 | |
| Directeur Financier/CFO | 18/08/2019 | 01/12/2019 | |
| Secrétaire Général | 01/10/2011 | - | |
Toray Advanced Composites UK Ltd.
 Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Toray Advanced Composites UK Ltd. engages in the manufacture and marketing of thermoset prepregs for aerospace and industrial markets. The company was founded on June 27, 1988 and is headquartered in Nottingham, the United Kingdom. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Sean D. Buckley
| The University of Hull | Undergraduate Degree |
| Robert H. Smith School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Director of Finance/CFO | 2 |
| Chief Administrative Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| CARMELL CORPORATION | Consumer Non-Durables |
| Entreprise privées | 3 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA. | Health Technology |
Toray Advanced Composites UK Ltd.
Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Toray Advanced Composites UK Ltd. engages in the manufacture and marketing of thermoset prepregs for aerospace and industrial markets. The company was founded on June 27, 1988 and is headquartered in Nottingham, the United Kingdom. | Process Industries |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Bourse
- Insiders
- Sean D. Buckley
- Expérience
